---
id: 204
title: Brain Abscess
category: clinical_syndromes
subcategory: central_nervous_system
tags: [brain-abscess, CNS, neurosurgery, aspiration, drainage, metronidazole, ceftriaxone]
difficulty: high
---

## Question

How are brain abscesses managed? Use **"Aspiration/Excision + Antibiotics (Ceftriaxone + Metronidazole + Vanc) × 6-8 Weeks"** framework.

## Answer

### **Pathogenesis:**

**Sources:**
1. **Contiguous spread** (40-50%): Sinusitis, otitis media, mastoiditis, dental infections
2. **Hematogenous** (25-35%): Bacteremia, endocarditis, lung abscess, congenital heart disease (R→L shunt)
3. **Direct inoculation** (10%): Neurosurgery, penetrating trauma
4. **Cryptogenic** (10-20%): No source identified

### **Microbiology:**

**Contiguous Spread (Sinusitis, Otitis, Dental):**
- **Streptococci** (viridans group, *S. milleri* group)
- **Anaerobes** (*Bacteroides*, *Prevotella*, *Fusobacterium*)
- **Polymicrobial** common

**Hematogenous:**
- ***S. aureus*** (endocarditis, IVDU)
- **Streptococci**
- **Gram-negatives** (*E. coli*, *Klebsiella*)

**Neurosurgery/Trauma:**
- ***S. aureus* (MSSA/MRSA)**
- **Gram-negatives** (*Pseudomonas*, *Enterobacter*)
- **CoNS**

**Immunocompromised:**
- ***Toxoplasma gondii*** (HIV CD4 <100)
- ***Nocardia asteroides*** (transplant, steroids)
- **Fungi** (*Aspergillus*, *Candida*, mucormycosis)

### **Clinical Presentation:**

**Classic Triad (20-50%):**
- **Headache** (most common, 70-90%)
- **Fever** (50-70%)
- **Focal neurologic deficits** (50-65%)

**Other:**
- **Altered mental status, seizures** (25-35%)
- **Nausea/vomiting** (increased ICP)
- **Papilledema** (25%)

**Presentation Often Subacute** (days to weeks)

### **Diagnosis:**

**MRI Brain with Contrast (Gold Standard):**
- **Ring-enhancing lesion** (capsule formation)
- **Central hypointensity** (necrotic core)
- **Surrounding edema**
- **Restricted diffusion** on DWI (high signal) - distinguishes from tumor

**CT Brain with Contrast:**
- **Ring-enhancing lesion**
- **Less sensitive** than MRI (especially posterior fossa, brainstem)

**Aspiration/Drainage:**
- **Sterile needle aspiration** or **surgical excision**
- **Send for Gram stain, culture (aerobic + anaerobic), fungal/AFB if indicated**
- **Do NOT perform LP** (contraindicated, risk of herniation)

**Blood Cultures:**
- **Positive in 10-25%** (if hematogenous source)

### **Treatment:**

**Empiric Antibiotics (Based on Source):**

**Contiguous (Sinusitis, Otitis, Dental):**
- **Ceftriaxone 2g IV q12h** + **metronidazole 500mg IV q8h** + **vancomycin 15-20 mg/kg IV q8-12h**
- **Covers:** Streptococci, anaerobes, *S. aureus*

**Hematogenous (*S. aureus*, Endocarditis):**
- **Nafcillin 2g IV q4h** (MSSA) OR **vancomycin** (MRSA) + **ceftriaxone** + **metronidazole**

**Post-Neurosurgery/Trauma:**
- **Vancomycin** + **cefepime 2g IV q8h** OR **meropenem 2g IV q8h**
- **Covers:** MRSA, *Pseudomonas*, resistant Gram-negatives

**Immunocompromised (HIV, Transplant):**
- **Add empiric coverage** for *Toxoplasma* (pyrimethamine + sulfadiazine) OR *Nocardia* (TMP-SMX)

**Pathogen-Directed (After Aspiration/Culture):**
- **Narrow based on susceptibilities**

**Duration:**
- **6-8 weeks IV antibiotics** (minimum)
- **Longer if:** Slow response, inadequate drainage, immunocompromised

### **Surgical Management:**

**Indications for Aspiration/Drainage:**
- **Abscess >2.5 cm** (stereotactic aspiration or excision)
- **Neurologic deterioration, mass effect**
- **Failed medical therapy** (enlarging despite antibiotics)
- **Gas-forming organisms** (anaerobes)
- **Fungal abscess**

**Medical Therapy Alone (Consider If):**
- **Abscess <2.5 cm** (cerebritis stage, early)
- **Multiple abscesses** (especially if poor surgical candidate)
- **Deep/eloquent location** (risk of surgical morbidity)

**Repeat Imaging:**
- **Serial MRI/CT** (weekly initially) to assess response

### **Adjunctive Therapy:**

**Corticosteroids (Controversial):**
- **Reduce cerebral edema** (dexamethasone 4-10mg IV q6h)
- **Use cautiously** (may impair abscess encapsulation, reduce antibiotic penetration)
- **Consider if:** Significant mass effect, risk of herniation

**Anti-Epileptic Drugs:**
- **If seizures** (levetiracetam, phenytoin)
- **Prophylaxis controversial** (some give for 1st week, then reassess)

### **Prognosis:**

**Mortality:** 10-20% (improved with modern imaging/neurosurgery)

**Long-Term Sequelae:**
- **Seizures** (30-50%)
- **Focal neurologic deficits** (20-30%)
- **Cognitive impairment**

### **Special Situations:**

***Toxoplasma* Encephalitis (HIV CD4 <100):**
- **Multiple ring-enhancing lesions** (basal ganglia, cortical-medullary junction)
- **Empiric trial:** Pyrimethamine + sulfadiazine + leucovorin × 2 weeks
- **Brain biopsy** if no response (r/o lymphoma)

***Nocardia* Brain Abscess:**
- **Associated pulmonary infection** (>50%)
- **TMP-SMX high-dose** + consider combination (amikacin, imipenem)
- **Duration:** ≥12 months

**Fungal (***Aspergillus*, Mucor***):**
- **Immunocompromised** (neutropenia, transplant)
- **Voriconazole** (*Aspergillus*) OR **liposomal amphotericin B** (mucormycosis)
- **Surgical debridement essential**

## Key Points

### **Ring-Enhancing Lesion + Restricted Diffusion:**
- **MRI with DWI:** Restricted diffusion (high signal) = abscess (vs. tumor)
- **Do NOT LP** (risk of herniation)

### **Empiric = Ceftriaxone + Metronidazole + Vancomycin:**
- **Covers:** Streptococci, anaerobes, *S. aureus*
- **Adjust based on source** (neurosurgery → add cefepime/meropenem for *Pseudomonas*)

### **Aspiration/Drainage + Antibiotics:**
- **Aspiration** if abscess >2.5 cm OR neurologic deterioration
- **Medical alone** if <2.5 cm, cerebritis stage, multiple abscesses

### **Duration: 6-8 Weeks IV:**
- **Minimum duration** (longer if slow response, inadequate drainage)

### **Do NOT LP:**
- **Contraindicated** (risk of herniation)
- **Diagnose with MRI/CT + aspiration**

### **Clinical Pearls:**
- **MRI ring-enhancing lesion + restricted diffusion** (DWI) = brain abscess
- **Empiric:** Ceftriaxone + metronidazole + vancomycin × 6-8 weeks
- **Aspiration/drainage** if >2.5 cm or neurologic deterioration
- **Do NOT LP** (herniation risk)
- **Sources:** Sinusitis, otitis, dental (contiguous), endocarditis (hematogenous), neurosurgery (direct)

## Sources

- [IDSA: Brain Abscess Guidelines 2024]
- [Neurosurgery: Brain Abscess Management 2024]

## Media

N/A
